These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9377332)

  • 1. [The use of Sandostatin in the combined treatment of surgical diseases of the pancreas].
    Saenko VF; Lifshits IuZ; Kozhara SP; Usenko AIu; Andreeshchev SA; Kryzhevskiĭ VV; Olenin VV; Beliaeva OA
    Lik Sprava; 1997; (3):126-7. PubMed ID: 9377332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible functional regression of insulinoma with prolonged octreotide.
    Craig CE; Gallen IW
    Postgrad Med J; 2002 Oct; 78(924):623-4. PubMed ID: 12415090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of administering a minimal dose of octreotide long-term prior to surgery for insulinoma: report of a case.
    Tanaka Y; Funahashi H; Imai T; Naruse T; Suzumura K; Oda Y
    Surg Today; 2000; 30(6):541-3. PubMed ID: 10883468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical treatment of benign insulinoma using octreotide LAR: a case report.
    Usukura M; Yoneda T; Oda N; Yamamoto Y; Takata H; Hasatani K; Takeda Y
    Endocr J; 2007 Feb; 54(1):95-101. PubMed ID: 17124362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The diagnosis and treatment of insulinoma and gastrinoma].
    Honda M; Ishibashi M
    Gan To Kagaku Ryoho; 2004 Mar; 31(3):337-41. PubMed ID: 15045936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of malignant insulin-producing pancreatic tumor treatment].
    Reutova EV; Orel NF; Besova NS; Artemova EV; Smirnova NB; Gorbunova VA
    Ter Arkh; 1999; 71(10):44-5. PubMed ID: 10612174
    [No Abstract]   [Full Text] [Related]  

  • 7. Sandostatin desensitization--a strategy useful for patients with carcinoid tumors, intolerant to sandostatin.
    Vinjamaram S; Iyer R
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):225-6. PubMed ID: 20922390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative efficacy of sandostatin and octreotide in surgical pathology of pancreas].
    Beburishvili AG; Mikhin SV; Spiridonov EG
    Khirurgiia (Mosk); 2002; (10):50-2. PubMed ID: 12449580
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of the long-acting somatostatin analogue octreotide in the management of insulinoma in three dogs.
    Simpson KW; Stepien RL; Elwood CM; Boswood A; Vaillant CR
    J Small Anim Pract; 1995 Apr; 36(4):161-5. PubMed ID: 7603057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric evidence of apoptosis in human pancreatic cancer xenografts treated with Sandostatin (octreotide).
    Zalatnai A; Szegedi Z; Bocsi J
    Anticancer Res; 2000; 20(3A):1663-6. PubMed ID: 10928088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No effect of the long-acting somatostatin analogue octreotide in patients with insulinoma.
    Timmer R; Koningsberger JC; Erkelens DW; Thijssen JH; Lips CJ; Koppeschaar HP
    Neth J Med; 1991 Jun; 38(5-6):199-203. PubMed ID: 1922592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulinoma revealed by recurrent falls in old age.
    Beauchet O; Kressig RW; Vischer UM; de Perrot T; de Saussure P
    J Am Geriatr Soc; 2005 Mar; 53(3):552-3. PubMed ID: 15743313
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined octreotide and peptide receptor radionuclide therapy ((90)Y-DOTA-TATE) in case of malignant insulinoma.
    Fischbach J; Gut P; Matysiak-Grześ M; Klimowicz A; Gryczyńska M; Waśko R; Ruchała M
    Neuro Endocrinol Lett; 2012; 33(3):273-8. PubMed ID: 22635083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of somatostatin and its analogues in pancreatic surgery and pancreatic disorders.
    Friess H; Büchler MW
    Digestion; 1996; 57 Suppl 1():97-102. PubMed ID: 8813484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sandostatin, alone and in combination with surgical castration, on pancreatic carcinogenesis in rats and hamsters.
    Visser CJ; van Garderen-Hoetmer A; Klijn JG; Foekens JA
    Int J Cancer; 1996 Mar; 65(6):827-32. PubMed ID: 8631599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of a large malignant gastrinoma on treatment with Sandostatin LAR: a case report.
    Granberg D; Jacobsson H; Oberg K; Gustavsson J; Lehtihet M
    Digestion; 2008; 77(2):92-5. PubMed ID: 18376130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulinoma effectively controlled with low dose of octreotide acetate].
    Fukuoka K; Matsushita M; Murase T; Yamamori I
    Nihon Naika Gakkai Zasshi; 2007 Dec; 96(12):2786-8. PubMed ID: 18203414
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hereditary neuroendocrine gastroenteropancreatic tumors and multiple endocrine neoplasia type 1].
    Scherübl H; Schaaf L; Raue F; Faiss S; Zeitz M
    Dtsch Med Wochenschr; 2004 Mar; 129(13):689-92. PubMed ID: 15026965
    [No Abstract]   [Full Text] [Related]  

  • 19. [Benign insulinoma. Efficacy of preoperative treatment for persistent hyperinsulinemia using a synthetic somatostatin analog].
    Esposito V; Esposito D; Lo Iudice G; Rispoli C; Verrillo A; D'Alessandro B
    Minerva Endocrinol; 1994 Mar; 19(1):33-7. PubMed ID: 8035768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin analog inhibits the growth of insulinoma cells by p27-mediated G1 cell cycle arrest.
    Aoki T; Motoi F; Sakata N; Naitoh T; Katayose Y; Egawa S; Miyazaki J; Unno M
    Pancreas; 2014 Jul; 43(5):720-9. PubMed ID: 24694834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.